Past, Present and Future Drugs for the Treatment of Obsessive- Compulsive Disorder
Keywords: (ERP); (SNRIs); (SPECT); (rTMS); Citalopram; Compulsions; D-Cycloserine; D-cycloserine; Duloxetine; ECA survey; Escitalopram; Fluoxetine; Fluvoxamine; Memantine; N-methyl-D-aspartate; Obsessions; Obsessive-compulsive disorder; PANDAS; Paroxetine; Pindolol; Sertraline; Venlafaxine; Y-BOCS; agitation; anti-obsessive new compounds; antidepressants; anxiety; augmentation; bilateral ante-rior capsulotomy; chronic; cingulotomy; clomipramine; cyto-chrome P450; deep brain stimulation; dorsolateral prefrontal cortex; egodystonia; gastro-intestinal distress; inositol; insomnia; leucotomy; morphine; nausea; neurosurgery; pathophysiology; pharmacological treatment; psychotherapy; resistance; riluzole; selective serotonin reuptake inhibitors; subcaudate tractotomy; symptoms; tricyclic antidepressant
Document Type: Research Article
Publication date: 01 October 2010
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.